Recent advances in breast cancer cell line research
- PMID: 38230499
- DOI: 10.1002/ijc.34849
Recent advances in breast cancer cell line research
Abstract
Breast cancer, a formidable global health challenge, needs continuous translational research to understand the complexity of mechanisms and improve therapeutic and diagnostic strategies. Breast cancer cell lines are of paramount importance as they significantly contribute to the initial stage of research to understand cancer biology. This review provides insights into targeted therapies and immunotherapies that have emerged using in vitro models and microbiome analysis. It focuses on therapeutic development using cell lines and the limitations of tumor heterogeneity and microenvironment. We explore the evolving landscape of breast cancer cell lines from two-dimensional (2-D) cultures to patient-derived xenograft (PDX) models advancing both fundamental and translational research. Patient-derived xenografts, cell line-derived xenografts (CDX), three-dimensional (3-D) cultures, organoids, and circulating tumor cells (CTC) models provide promising alternatives that capture the intricacies of the tumor microenvironment. This review bridges the gap between traditional cell lines and newer developments exploring the therapeutic and diagnostic advancements and needs for cell lines to expedite the progress in breast cancer research and treatment.
Keywords: breast cancer; cell cultures; cell line development; therapeutics; xenografts.
© 2024 UICC.
References
REFERENCES
-
- WHO. Breast Cancer Details. 2023. Accessed July 2023. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
-
- Globocan. TGCO. Estimated Age-Standardized Incidence Rates (World) in 2020, India, Both Sexes, All Ages (excl. NMSC). 2020. Accessed July 2023. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-she...
-
- Fatima I, Singh AB, Dhawan P. MASTL: a novel therapeutic target for cancer malignancy. Cancer Med. 2020;9(17):6322-6329.
-
- Polisety A, Misra G, Rajawat J, Katiyar A, Singh H, Bhatt AN. Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation. Med Oncol. 2022;39(5):100.
-
- Misra G, Rajawat J, Pal R, Smith JC, Kumar A. Targeted inhibition of MASTL kinase activity induces apoptosis in breast cancer. Life Sci. 2023;334:122250.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous